Comparison of the four malignancy risk indices in the discrimination of malignant ovarian masses: A cross-sectional study.

Journal of Gynecology Obstetrics and Human Reproduction
Mustafa N AliAhmed M Abbas

Abstract

To evaluate the accuracy of the four malignancy risk indices to distinguish benign from malignant ovarian masses MATERIALS AND METHODS: This was an observational cross-sectional study conducted on 155 patients between January 2016 and January 2019. Women with ovarian masses planned for surgical management were recruited from the outpatient Gynecology clinic of the hospital. The risk of malignancy index (RMI 1-4) was calculated for all women with ovarian masses. Biopsies obtained from the ovarian masses after the surgical intervention was sent to the pathology lab for histopathological examination. The histopathologic diagnosis of the ovarian masses was considered the gold standard for diagnosis. The participants' mean age in the group of patients with benign masses was 33.50 ± 14.53 years versus 45.09 ± 13.67 years in the malignant group. The two most prominent features in the malignant group were solid areas in 85.3 % of malignant masses and about 91.2 % of malignant masses showing size <7 cm in their largest diameter. The RMI's most sensitive individual parameter was the CA-125 level, while the lowest sensitivity was for the menopausal status. RMI 2 had the highest sensitivity of 76.47 %, while RMI 1 and 3 had the highest spe...Continue Reading

References

Mar 17, 2004·European Radiology·Kaori Togashi
Apr 3, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Leo J SchoutenStephanie A Smith-Warner
Jan 22, 2009·Obstetrics and Gynecology·Peggy GeominiBen W J Mol
Mar 31, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Yorito YamamotoTakao Fukaya
Dec 5, 2009·Gynecologic Oncology·Petronella A J van den AkkerLeon F A G Massuger
Mar 24, 2010·Obstetrics and Gynecology·John M McDonaldJohn R van Nagell
May 18, 2011·Journal of Oncology·Brandon J D ReinAshok Agarwal
Aug 10, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Petronella A J van den AkkerLeon F A G Massuger
Oct 15, 2011·Journal of Gynecologic Oncology·Erhan AktürkIskender Başer
Nov 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Caroline Van HolsbekeDirk Timmerman
Jun 1, 2012·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·C A HartmanS Derchain
Oct 9, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Hakki Sencer SimsekTayfun Gungor
Jul 18, 2015·Obstetrics and Gynecology International·Aliya B Aziz, Nida Najmi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Vojnosanitetski pregled. Military-medical and pharmaceutical review
Milan TerzićNebojsa Ladjević
The Australian & New Zealand Journal of Obstetrics & Gynaecology
Yin Nin ChiaNeville F Hacker
© 2021 Meta ULC. All rights reserved